Skin and Soft Tissue Infection
📧 Sign up to get email alerts when something new happens for Skin and Soft Tissue Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Trial of Reducing Inpatient Antibiotic Durations in Children [Phase 4]
A Phase 4 trial assessing shorter inpatient antibiotic courses in children with pneumonia, skin and soft tissue infection, and urinary tract…
-
FDA approval · 2026-04-07FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application from B. Braun Medical Inc. for Cefepime hydrochloride and dextrose, adding this formulation under th…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Staph Household Intervention for Eradication (SHINE) [Phase 4]
Phase 4 clinical trial update on SHINE evaluating a household intervention to eradicate Staphylococcus aureus/MRSA and prevent skin and soft…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment [Phase 2]
This Phase 2 trial compares doxycycline with trimethoprim-sulfamethoxazole for MRSA-related skin infections and reports short- and long-term…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: INSPIRE Trial for Skin and Soft Tissue Infections [NA]
The INSPIRE trial evaluating treatment for skin and soft tissue infections has completed enrollment and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Comparing Oral Versus Parenteral Antimicrobial Therapy [Phase 4]
Phase 4 clinical trial comparing oral versus parenteral antimicrobial therapy has been terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: A Pilot Study to Evaluate Skin Swabbing With Chlorhexidine to Prevent Skin And Soft Tissue Infections Among People Who Inject Drugs [Phase 4]
A Phase 4 pilot study evaluated whether chlorhexidine skin swabbing can prevent skin and soft tissue infections in people who inject drugs; …
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI) [Phase 2]
Phase 2 trial assessing safety, immunogenicity, and efficacy of the GSK3878858A Staphylococcus aureus vaccine in healthy adults and in adult…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis
This is an update on the TriVerity diagnostic trial for emergency department patients with suspected infections and suspected sepsis. The st…
-
FDA label_change · 2022-09-01FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for amoxicillin and clavulanate potassium submitted by Northstar RxLLC, resulting in updated labelin…
-
FDA approval · 2020-09-09FDA Approved: CEFTRIAXONE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Ceftriaxone and Dextrose from B. Braun Medical, resulting in an updated/expanded approval for th…
-
FDA approval · 2020-01-27FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Amoxicillin and clavulanate potassium by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23) [Phase 3]
Phase 3 clinical trial comparing omadacycline to linezolid for acute bacterial skin and skin structure infections has completed with results…
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Tygacil Drug Use Investigation
Pfizer reports a completed trial investigating tigecycline (Tygacil) for intra-abdominal infections and skin infections, with results posted…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure [Phase 3]
A Phase 3 population PK study evaluating multiple 10 mg/kg doses of daptomycin (Cubicin) in critically ill patients with bacteremia, endocar…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus [Phase 2]
Phase 2 clinical trial evaluating treatment of uncomplicated skin and soft tissue infections caused by community-associated MRSA has complet…
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management [Phase 4]
Phase 4 clinical trial assessing the utility of trimethoprim-sulfamethoxazole in managing skin abscesses; results posted.
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: MRSA Colonization and Control in the Dallas County Jail [NA]
A completed clinical trial evaluating MRSA colonization and control strategies in a Dallas County jail.
-
CLINICAL_TRIALS withdrawal · 2012-12-31Clinical Trial Update: Clinical Usefulness of Mic/Breakpoint Ratio and Penetration in Tissues. A Prospective Study of Clinical Validation [NA]
A clinical trial evaluating MIC/breakpoint ratio and tissue penetration for skin and soft tissue infections has been withdrawn.
-
FDA approval · 2012-02-17FDA Approved: CEFACLOR — Original Application (Azorian Pharma, LLC)
The FDA approved Azorian Pharma, LLC's original application for Cefaclor (generic) for treating susceptible bacterial infections including r…
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA [Phase 3]
Phase 3 trial comparing retapamulin to linezolid for staphylococcal skin infections including impetigo; results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002) [Phase 3]
Phase 3 clinical trial update for MK-3009 in Japanese patients with MRSA-related skin and bloodstream infections; results for MK-3009-002 we…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin [Phase 2, Phase 3]
A completed Phase 2/3 trial comparing oral levofloxacin to ciprofloxacin for adults with mild-to-moderate skin and soft tissue infections, i…
-
FDA approval · 2010-11-29FDA Approved: CEFAZOLIN — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Cefazolin (cefazolin sodium) from Fresenius Kabi USA, LLC, updating an already approved prod…
-
FDA approval · 2010-10-21FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Hospira, Inc)
FDA approved Hospira's piperacillin/tazobactam combination under an original ANDA application, providing a generic version of the antibiotic…